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We studied the binding of [l~I]Tyrn-somatostatin-14 and p2Sl]Leus,D-Trp-'2,Tyr2S-somatostatin-28 to frozen, unfixed sections of 
C57BL/6J mouse eyes with autoradiography. Specific binding of both ligands occurred in 3 maxima, a broad band extending from the 
retinal ganglion cell to the inner nuclear layers, a narrow and inconstant band over the outer plexiform layer, and a band over the reti- 
nal pigment epithelium and choroid. We quantified the label over the inner plexiform layer and found evidence f~r a ,ingle, saturable 
binding site after Scatchard analysis of saturation binding data. With p2Sl]Tyrn-somatostatin-14 the dissociation constant (Ko) was 
1.48 nM and the total number of binding sites (Bronx) was 68 fmol/mg protein; in competition experiments the inhibitory binding con- 
stant (Ki) was 900 pM for somatostatin-14 and 350 pM for somatostatin-28. With [t2SI]LeuS,D-Trp22,TyrXS-somatnstatin-28, K d was 625 
pM and B~a x was 69 fmol/mg protein: in competition experiments K i was 4.58 nM for somatostatin-14 and 710 pM for somatostatin-28. 
These results demonstrate the existence of somatostatin receptors in the inner plexiform layer of the retina that appear to have greater 
specificity for somatos.'atin-28 than for somatostatin-14. 
INTRODUCTION 
Two molecular  forms of somatostatin,  one com- 
posed of  14 and the other composed of 28 amino 
acids, have been found in the retinas of various mam- 
mals I°Al'm'!g'23. Immunohistochemical studies on 
mammalian retinas have shown somatostatin to be 
located in the processes of  amacrine cells in the inner 
plexiform layer and in processes of  unidentified cells 
in the outer  plexiform layer 7'23,27. In the goldfish n 
and the macaque 12 the processes of these cells in the 
inner plexiform layer are presynaptic to amacrine, 
ganglion and bipolar  cells. 
Exogenous somatostatin,  when applied in solu- 
tions superfusing the retina, has been shown to affect 
the retinal responses to light. Nanomolar  concentra- 
tions increase the amplitude of  the extracellularly-re- 
corded,  massed oscillatory potentials of the mudpup- 
py eyecup preparat ion 3°, and affect the responses of 
rabbit  36 and goldfish 31 retinal ganglion cells in a vari- 
ety of ways. The mouse retina can be studied in an 
isolated, superfused preparat ion t'24 and many mu- 
tants with defective visual f~anction are available (see 
ref. 24 for review). Appl icat ion of somatostatin-28 in 
low (~< 10 riM) concentrat ions affects the responses of 
on-center retinal ganglion cells to small, centered 
light stimuli 25. 
We have searched for retinal receptors for somato-  
statin in order  to understand the mechanism for so- 
matostatin action. To do so we have employed quan- 
titative autoradiography because this method allows 
quantification of the label in a given location and per- 
mits small amounts of tissue to be studied. Using this 
method,  we have found specific membrane receptors 
for somatostatin in the inner and outer  plexiform lay- 
ers of the retina. We characterized the receptors in 
the inner plexiform layer,  and found them to have a 
higher affinity for somatostatin~28 than for somato-  
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statin-14 and to have a dissociation constant within 
the range of concentration of exogenous somatostat- 
in found to affect the responses of mouse retinal gan- 
glion cells. 
MATERIALS AND METHODS 
Mice from the C57BL/6J strain (both sexes, 3-7 
months of age) were used. They were maintained 
with a 12 h light/12 h dark cycle, and were sacrificed 
by cervical dislocation (3-4 h after onset of light at 
07.00 h). 
Quantitative autoradiography 
The eyes were marked with a pen at the canthus, 
removed, placed in isopentane at -140 °C for rapid 
freezing, stored overnight at -20 °C, and sectioned 
(at 10/~m) the next day. The mark on the canthus was 
used to orient the eye to make sections parallel to the 
optic axis. The sections v,e~e collected on slides and 
stored at -20 °C overnight. Cerebral cortices were 
also frozen in isopentane at -140 °C. We followed 
the incubation procedure of Maurer and Reubi 13. 
The sections were preincubated (2 mM CaCl 2, 5 mM 
KCI, 50 mM Tris-HCl, pH 7.4, 10 rain, 21 °C), 
washed twice (50 mM Tris-HCl, pH 7.4, 2 min, 
21 °C), and drained of excess solution.. An incubation 
solution was then applied to the sections for 40 min 
(21 °C). The incubation solution always contained 10 
mM MgCl2, 1% bovine serum albumin, 40/~g/ml ba- 
citracin, and 170 mM Tris-HCl, pH 7.4. For satu- 
ration binding experiments the incubation solution 
also contained radiolabeled somatostatin, either 
[125IlTyrU-somatostatin-i~4 (Amersham) in concen- 
trations from 30 pM to 5 aM or [1251]LeuS,D-Trp 22, 
Tyr2S-somatostatin-28 (iodinated using the chlora- 
mine-T method, see Yamada 33 in concentrations 
from 50 pM to 2.5 nM). In competition experiments 
i 
the incubation solution contained either 250 pM 
[12Sl]TyrH-somatostatin-14 or 20 pM [125I]LeuS,o- 
Trp",Tyr"-somatostatm-28 and one of many con- 
centrations of unlabeled competitor (either somato- 
statin-14, somatostatin-28, somatostatin-28(1-14)or 
bombesin). To determine non-specific binding, 10 
/~M of the appropriate molecular form of somatostat- 
in was added. After incubation the sections were 
washed (0.25% bovine serum albumin and 170 mM 
Tris-HCi, pH 7.4, twice for 5 min, 5 °C), dried rapid- 
iy by allowing dichlorodifluoromethane gas to flow 
over them, and placed in X~ray cassettes opposed to 
3H-ultrofilm (LKB). The slides upon which the sec- 
tions were mounted were coded before being placed 
in the cassettes. Calibrated, radioiodinated brain 
paste standards 29 were placed in the cassette together 
with the sections for 1-5 days. The film was devel- 
oped (in D-19 for 4 min, 18 °C). The histological sec- 
tions and the autoradiograms were examined with a 
stereomicroscope and a dark-field compound micro- 
scope in order to identify labeling (or lack of label- 
ing) caused by histological artifacts. The autoradio- 
grams were superimposed upon the sections and 
viewed With the stereomicroscope in order to identify 
the part of the autoradiogram that had been in con- 
tact with the inner plexiform layer. ~a some cases we 
also needed to compare the section and autoradio- 
gram with the dark-field microscope to make the 
identification. Density was measured with a micro- 
photometer equipped with a current-regulated pow- 
er supply and 60 ~m diameter measurement aperture 
(referred to the specimen plane) or an Eikonix scan- 
ning microphotometer with a 7/~m pixei size (re- 
ferred to the specimen plane). 
Calibration of the concentration of label was done 
(or each experiment in the following way. The optical 
density of the brain paste standards was measured 
and plotted against the concentration of isotope in 
the brain paste (dpm/mg protein). For short exposure 
times these plots could be fitted by a straight line 2 
which was later used to calculate the concentration of 
label in the measured regions of th~ sectioned tissue. 
We used emulsion autoradiography to help loca- 
lize the retinal layers to which binding occurred. We 
used either the sandwich technique of Young and 
Kuhar 34 or the dry loop technique of Caro 3 to per- 
form autoradiography using fine grain emulsion (see 
Fig. 2). The t251-1abel that we used has the advantage 
over 3H-label~ of being insusceptible to quenching ar- 
tifact s. The mean free path of 1251 is somewhat longer 
than that of 3H, but sufficiently short for ~25I label to 
be helpful in localizing labeling to specific retinal lay- 
ers. However, 1251 label cannot provide information 
about cellular localization in the 10/~m thick sections 
that we used. 
Binding to membrane fractions 
Retinas were isolated -~4'25 in a solution containing 
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150 mM NaCI and vortexed to remove ~he photore- 
ceptor outer  segments L~. The retina or cerebral cor- 
tex was homogenized in glass-teflon Randotti homo- 
genizers in ice cold 0.32 M sucrose. The homogenate 
was centrifuged (5 rain, 1000 g); the supernatant was 
re-centrifuged (20 min, 20,000 g) to obtain the P2 
membrane  fraction, within which the receptor-rich 
synaptosomal fraction is contained 5"21, and the pellet 
was re-suspended in buffer (Tris-HCl, pH 7.4). Bind- 
ing assays were performed upon 100 ~! samples con- 
taining 50/~g protein as described by Reubi et al.16. 
Protein content was estimated by the method of Sed- 
mak and Grossberg 2°. Statistical analysis of binding 
data was done with ANOVA (Type 1, mixed design) 
followed by the Duncan test). 
RESULTS 
Confirmation of the validity of  the method using brain 
tissue 
We made crude mitochondrial fractions of the 
mouse cerebral cortex and retina and performed re- 
ceptor bind/rig assays in parallel on each tissue using 
250 pM [125|]Tyr"Lsomatostatin-14. We found that 
specific binding was proportional to the amount of 
membrane protein in each sample. The specific bind- 
ing to the cortical fractions with 250 pM ligand was 27 
fmol/mg protein, a value similar to that obtained for 
the binding of this ligand to rat cortical membranes 
under similar incubation conditions (25 fmol/mg pro- 
tein) 16. The specific binding of this ligand to the reti- 
nal P2 fraction was 2 -3  times less than the specific 
binding to cortical P2 fractions with the same concen- 
tration of ligand. The non-specific binding was 
30-50% of the total binding in both cortex and reti- 
nal. 
We examined the pattern of labeling in film auto- 
radiograms after incubation of coronal and parasagit- 
tal sections of the brain with [1251]Tyrml-somatostatin- 
14. We found the distribution of label to be similar to 
that described by Tran et al. 27, Maurer and Reubi 13 
and Lcroux et al. 9 in rats; the hippocampus and 
amygdala were generally heavily labeled; the cortex 
was heavily labeled, with a band of dense label over 
the infra-granular layers; non-specific binding was 
uniform over the sections. We simultaneously incu- 
bated sections of retinas and cortex with 100 or 250 
pM of [1251]TyrH-somatostatin.14 and found the spe- 
eific binding to the retina to be 2 -3  times less than the 
specific binding to the infra-granular layers of  the 
cortex. These results confirmed those obtained with 
crude mitochondrial fractions. We characterized the 
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Fig. I. Film autoradiograms (A, B, D and E) and the distribu- 
tion of optical transmission (C and F) of sections of eyes that 
were incubated in [1251]Tyrn-somatostatin-14 (A-C) and 
!125I]LeuS,o-Trp2-',Tyr'-S-somatostatin-28 (D-F). Total binding 
Is shown in A and D. Non-specific binding (B and E) was ob- 
tained in the presence of 10FtM unlabeled peptide (SS-14 in B 
and S-28 in E). The straight lines in the autoradiograms show 
the path along which optical transmission was measured. The 
layers of the retina that underlie the scan par.h were identified 
from the section and are indicated in the plots in C and F. RPE, 
retinal pigment epithelium and choroid; ROS, rod outer seg- 
ments; ONL, outer nuclear layer; OPL, outer plexiform layer; 
INL, inner nuclear layer; IPL, inner plexiform layer, and GC, 
ganglion cell layer. Note the high specific binding (hatched) in 
the inner plexiform layer. Scale bar = 601~m. 
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Fig. 2. Cresyl violet-stained section (A) and autoradiograms (B and C) of adjacent sections incubated with [i2SI]Tyr"-somatostatin. 
14. Total binding is shown in B and non-specific binding, determined in the presence of 10gM unlabeled somatostatin-14, in C. Note 
the maxima of specific binding associated with the plexiform layers in (B). Abbreviations as in Fig. 1. Scale bar = 100Ftm. 
Anatomical localization of binding in the retina 
Three maxima of total binding density were found 
with both [t251]TyrtLsomatostatin-14 and [IZSl]LeuS, 
D-Trp22,TyrlZS-somatostatin-28. Two of these maxi- 
ma occurred in the retina and one in the retinal pig- 
ment epithelium (RPE)-choroid complex. These 
maxima did not appear to have different intensities in 
the central and peripheral parts of the eye (Fig. 1). 
Emulsion autoradiography (see Materials and Meth- 
ods, and Fig. 2) helped to identify the labeled retinal 
layers. The densest labeling occurred in a broad band 
over the inner plexiform layer and inner margin of 
the inner nuclear layer. A second thin and less con- 
stant band was found over the outer plexiform layer 
(Fig. 1). Non-specific binding was lower and more 
uniform than total binding (Figs. 1, 2). Non-specific 
binding was higher in the RPE-choroid complex 
than in the retina. The qualitative pattern of labeling 
in the retina was similar with both ligands. However, 
the non-specific labeling of the RPE-choroid com- 
plex was markedly lower with [125I]LeuS,D-Trp22, 
Tyr2Lsomatostatin-28 than with [125I]Tyrll-somato- 
statin- 14. 
The wide band of labeling usually fell over the in- 
ner half of the retina (see Materials and Methods) 
and encompassed the region from the retinal gan- 
glion cell layer to the outer plexiform layer (Fig. 1C, 
F), a distance of about 120/~m. We performed fur- 
ther measurements upon the innermost 60 g~n of this 
band. These measurements were centered ,pon the 
inner plexiform layer. 
Saturation binding studies 
We measured the time-course of binding of 
[125I]TyrlLsomatostatin-14 to retinal sections and 
found that the binding reached a plateau from 40 to 
60 min, consistent with previous findings z2"zs. All fur- 
ther measurements were made with 40 min incuba- 
tions. 
Binding of []zSI]TyrlLsomatostatin-14 was mea- 
sured using concentrations of 30 pM-5 nM. Non-spe- 
cific binding was determined in the presence of 10#M 
unlabeled somatostatin-14, and accounted for 
30-70% of the total binding (Fig. 3). Specific binding 
was found to saturate at about 2.5 nM. Scatchard 
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Fig. 3. Binding of ['251]Tyrll-somatostatin-14 t( the inner plexi- 
form layer as a function of ligand concentration. :'x. total bind- 
ing; ©, non-specific binding: and O, specific bind,~g. Data are 
from 7 experiments (mean -+ S.E,M.). 
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Fig. 4. Scatchard plots of specific/3inding to the inner plexiform 
layer for []zSI|Tyrt Lsoma~ostatin-14 (A, taken from Fig. 3) and 
[m~I]LeuS,D-TrpZ2,Tyr~-somatostatin-28 (B) taken from two 
experiments. 
analysis (Fig. 4A) of the saturation data revealed a 
single class of binding sites with a dissociation con- 
stant (Kd) of 1.48 nM. The total number of binding 
sites (Bronx) was 68 fmol/mg protein. 
We studied the binding of [12SI]LeuS,D-Trp~,Tyr25- 
somatostatin-28 using concentrations from 50 pM to 
2.5 nM. Non-specific binding was measured in the 
presence of 10/zM unlabeled somatostati[~-28~ and 
accounted 20-50% of the total binding. Scatchard 
analysis (Fig. 4B) revealed the presence of a single 
class of binding sites with K d of 625 pM and Bma~ of 69 
fmol/mg protein. 
Binding competition studies 
The ability of somatostatin-14, somatostatin-28, 
S r t m ~ 4 " ~  nd. .~ 1 • . . . . . . .  sta,n-28(,-14~ and bombesin to compete 
with the binding of [125I]Tyrn-somatostatin-14 or 
[1251]LeuS,D-Trp22,Tyr2S-somatostatin-28 to retinal 
sections was measured. In ~oncentrations as high as 1 
pM, somatostatin-28(1-14) did not significantly re- 
duce the binding of either ligand. Bombesin, in con- 
centrations as high as 1/~M, did not significantly re~ 
duce the binding of [125I]TyrU-somatostatin-14. We 
did not test bombesin with the other ligand. 
Somatostatin-28 was a more potent competitor 
than somatostatin-14 against both [1251]TyrlLso- 
matostatin-14 and [~ZSl]LeuS,o-Trp22,Tyr25-somato- 
statin-28 (Figs. 5, 6). The mediarl inhibitory conce~- 
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Fig. 5. Competition for the specific binding of [12SI]Tyrll-so- 
matostatin-14 by somatostatin-14 (SS-14, I"1) and somatostatin- 
28 (SS-28, ©). Average data from 7 experiments (SS-14) and 4 
experiments (SS-28). The inhibitory binding constant (Ki, cal- 
ctqated from the formula of Cheng and Prusoff 3) was 900 pM 
for somatostatin-14 and 350 pM for somatostatin-28. 
tration tiCs0 ) against [1251]TyrU-somatostatin-14 was 
640 pM for somatostatin-14 and 420 pM for somato- 
statin-28. Against [12Sl]LeuS,D-Trp22,Tyr25-somato- 
statin-28, IC5~ was 3.77 nM for somatostatin-14 and 
1.2 nM for somatostatin-28. 
Statistical evaluation of the binding competition 
with ANOVA showed that binding of [12Sl]Tyr-so- 
matostatin-14 was significantly less in the presence of 
unlabeled somatostatin-28 than in the presence of 
unlabeled somatostatin-14, for all of the concentra- 
tions that were studied (Fsa = 7.58, P < 0.05). The 
group x treatment interaction was not statistically 
significant, indicating a similar dependence of 
[125I]TyrU-somatostatin-14 binding upon the concen- 
tration of both competitors. 
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Fig, 6. Competition for the specific binding of [lZSl]LeuS,D- 
2~  Trp ",Tyr25-somatostatin-28 by somatostatin-14 ($$-14, r-l) and 
somatostatin-28 (SS-28, O), Average data from 2 experiments. 
For somatostat/n-14, K i was 4.58 nM, and for somatostatin-28 
K i was 710 pM. 
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The binding of [1251]Leus,D-Trp22,TyrZ~-somato -
statin-28 was also significantly less in the presence of 
unlabeled gomatostatin-28 than in the presence of 
unlabeled somatostatin-14, for all concentrations 
tested (F3a = 19.3, P < 0.05). In this case the group 
x treatment interaction was statistically significant 
(Fgas = 7.74, P < 0.001), indicating that the binding 
of [12Sl]LeuS,D-Trp22,Tyr2S-somatostatin-28 had a 
concentration dependence that was different for un- 
labeled somatostatin-28 than for unlabeled somato- 
statin-14. 
DISCUSSION 
We found evidence for somatostatin receptors in 
the inner and outer plexiform layers of the retina, 
and characterized the receptors in the inner plexi- 
form layer using labeled analogs of somatostatin-14 
and somatostatin-28. A single class of binding sites 
are present, with a dissociation constant of 1.5 nM for 
somatostatin-14 and 0.6 nM for somatostatin-28, and 
a density of about 70 fmol/mg protein. These binding 
sites possess the appropriate properties and occur in 
the appropriate location for mediating physiological 
effects of somatostatin, and are therefore probably 
somatostatin receptors. 
Three measurements indicate that somatostatin-28 
is somewhat more potent than somatostatin-14 in 
binding to retinal somatostatin receptors. 
First, the dissociation constant for the binding of 
[t25I]Tyrlt-somatostatin-14 is twice that for binding 
of [12Sl]LeuS,o-Trp22,Tyr25-somatostatin-28. Second- 
ly, the median inhibitory concentration (ICs0) of so- 
matostatin-14 is 3 times the ICs0 of somatostatin-28 
against [125I]TyrlLsomatostatin-14. Finally, the ICs0 
of somatostatin- 14 is 4 times the ICs0 of somatostatin- 
28 against [125I]LeuS,D-Trp22,TyrELsomatostatin-28. 
Somatostatin-like immunoreactivity has been 
found in the retinas of many species. In the goldfish 1~ 
and the macaque 12 the immunoreactive cells are pre- 
synaptic to amacrine, ganglion and bipolar cells in 
the inner plexiform layer. Our finding of somatostat- 
in receptor binding in the inner plexiform layer is 
thus consistent with a role for the cells with somato- 
statin-like immunoreactivity ill signal transmission. 
However, limitations inherent to our method do not 
permit cellular iocalizat~o~ of the somatostatin re- 
ceptors. It is of interest to note that receptors for 
GABA, benzodiazepine, dopamine, adrenaline and 
acetylcholine are also found in the inner plexiform 
layer of mammalian retinas 37. 
A few experiments have been reported of effects 
of exogenous somatostatin upon the responsiveness 
of the retina 24"z5"30'35'36. However, without knowing 
that somatostatin receptors with the appropriate 
properties occur in the retina we might ascribe these 
effects to a non-specific action of the peptide. Our 
finding of a specific, high affinity receptor for so- 
ma~.~statin in the synapse-rich inner plexiform layer 
lends support to the interpretation that somatostatin 
has a physiological role(s) in the retina. 
Retinal somatostatin receptors have a dissociation 
constant within the range found ~or the receptors in 
various regions of the brain 9"16A7"21"22'32. However, 
the density of receptors in the retina is only 40-50 % 
of that in the brain t6"17"21"22. Perhaps the lesser den- 
sity explains the less intense labeling we observed in 
retinal sections when compared with brain sections. 
Similarly, the inhibitory dissociation constants (Ki) 
we found for somatostatin-14 and -28 were within the 
range found for these compounds in brain tis- 
sue 9'17'28. We found that somatostatin-28 is more po- 
tent than somatostatin-14 in binding to retinal recep- 
tors. The same order of relative potency was found 
for cortical tissue by Ruebi et al. 17 and Leroux et al. 9 
and for pituitary tissue by Snkant and Pate121"22. It is 
of interest to note that the more potent somatostatin- 
28 is also more abundant than somatostatin-14 in the 
mouse retina (T. Yamada and L. Aldrich, in prepara- 
tion). 
In conclusion, we found specific, high affinity re- 
ceptors for somatostatin in the inner plexiform layer 
of the mouse retina. This finding, taken together with 
immunohistochemical and physiological findings, 
supports the hypothesis that the neuropeptide so- 
matostatin is either a neurotransmitter or neuromo- 
dulator in the retina. 
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